Navigation Links
Thad Bench of Benchworks to Participate in 8th Annual Life Science Chief Executive Officer Forum
Date:3/22/2017

Benchworks CEO Thad L. Bench Sr. will participate in the 8th Annual Life Science Chief Executive Officer Forum on March 23-24 in San Diego. The event is a gathering of executive leadership from companies in the pharmaceutical, biotechnology and medical device and diagnostic industries.

Benchworks Vice President Christian Meyer will also participate in the forum. Participants will discuss the future of the life science industry and current challenges organizations face. The event is designed for education, engagement and knowledge sharing. A live polling feature will enable the audience to actively participate.

Thad Bench will interview the Founder, President & CEO of ARMO Biosciences, Peter Van Vlasselaer, PhD. The conversation will focus on Vlasselaer’s entrepreneurial experience and the need for leadership excellence in the biotech industry and will be conducted in front of an audience of attendees.

In addition, Thad Bench will serve as the chairperson for the forum events on March 24. He will introduce each session which include panel discussions on these topics:

•Assessing the Impact of Pricing Pressures on the Pharmaceutical Industry
•Regulatory Challenges and Solutions for Value-Based Pricing
•Business Models & Medical Device Contracting in a Value-Based Healthcare Environment
•Delivering on the Promise of Precision Medicine: Analysis of Impact on the Life Science Industry
•The Convergence of Technology & Healthcare

Commenting on the event, Thad Bench said, “This forum brings together leaders of the highest caliber who will share their knowledge and experiences in the biotech industry. It is an exciting opportunity for people to learn and benefit from their wisdom and experience. As a commercialization partner, we at Benchworks look forward to networking with executives to discuss how we can help them build out operations and provide strategic thinking, top-tier creative, and outstanding project management.”

About Benchworks
Benchworks, a comprehensive marketing services agency headquartered in Chestertown, Maryland, was founded in 1991. With offices in Philadelphia and Boston, the company specializes in the design, production, and launch of complete marketing and branding services. Clients include a wide variety of companies in the life science, pharmaceutical, beverage, manufacturing, and education industries in North America and Europe. For additional information, visit http://www.benchworks.com or call 800-536-4670.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14167294.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Formaspace Debuts Innovative New Lab Bench at Pittcon 2017
2. Groundbreaking Technology in Drug Discovery: Shorten Wet-Bench Experimental Time and Reduce Animal Use in Research
3. Benchling Announces First Of Its Kind Molecular Biology 2.0 Software Enabling Scientists To Run Thousands Of Experiments At Once
4. Benchworks Marks 25 Years of Excellence in Life Science Marketing
5. Innovation in Clinical Research awarded to CEO of Benchmark Research
6. Benchmark Research Named Best Clinical Trial Site at VIE Awards
7. Benchmark Research announces the promotion of two long-standing Principal Investigators.
8. Now Open: iLab Solutions’ Sixth Annual Core Facility Management Benchmarking Survey
9. Benchmark Research Announced New Operating Structure
10. ResearchDx Appointment of New Chief Medical Officer to Meet NIH Push for Precision Medicine in Expediting Bench to Bedside" Strategies for Disease Treatment
11. With Disclosure of Recently Met Benchmarks for Its Adult Tissue Stem Cell Counting Technology, Asymmetrex Targets Applications to Enable Gene-Editing Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2020)... ... June 29, 2020 , ... The ... purchasing contracts to its membership, recently named BioFit Engineered Products an ... opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... develop a vaccine or drug treatment. In an effort to better understand the ... released the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV ... laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today ... 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes ... consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
Breaking Biology Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a ... purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture ... facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible ...
(Date:6/28/2020)... BASEL, Switzerland (PRWEB) , ... ... ... leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that ... oncology company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical ... clinical data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... in hospitalized patients with severe COVID-19. This is the first study of an ...
Breaking Biology News(10 mins):